UPDATE - We have won! The LCDs are all being withdrawn. The chances given that this would happen were 1-3% so we really made an impression. There were so many patients, doctors, and organizations helping and pushing back on these LCDs. I am full of joy knowing that patients will continue to have choices made in conjunction with their doctors. This victory was unexpected but I am beyond grateful that it turned out like this. Congratulations to everyone who helped to secure this success. Sending you all much appreciation for the support! Please take time to review the heartfelt comments below.

In the U.S., there are over 3 million Americans with glaucoma. It is a complex disease and patients respond differently to treatment, thus, there is a need for multiple treatment options. Recently, several MACs (Medicare Administrative Contractor) have announced LCDs (local coverage determinations) that limit the role of MIGS (Minimally Invasive Glaucoma Surgery) in glaucoma treatment. This does not only affect Medicare patients as commercial insurance usually follows medicare determinations. As a glaucoma patient, this is heartbreaking for many reasons including limiting treatment options for patients and requiring doctors to do more invasive surgeries for mild to moderate glaucoma. Companies will also move away from research and development in the glaucoma space if their devices are not reimbursed, and thus, not used by doctors. This is absolutely devastating for patients. Glaucoma affects African-Americans, Hispanics, and those over 60 disproportionately and this will only limit access to care. These changes are scheduled to come into effect on December 24, 2023 so it is imperative that we act now to save our sight!

For more info please read https://www.glaucomaphysician.net/issues/2023/sept...

In addition, you can email the Administrator of Medicare and Medicaid - Chiquita Brooks LaSure at Chiquita.Brooks-LaSure@cms.hhs.gov

@glaucoma_coach